Shattuck Labs Inc (NAS:STTK)
$ 7.915 0.075 (0.96%) Market Cap: 376.37 Mil Enterprise Value: 265.75 Mil PE Ratio: 0 PB Ratio: 2.92 GF Score: 62/100

Shattuck Labs Inc Present at Needham Healthcare Conference (Virtual) Transcript

Apr 14, 2021 / 03:00PM GMT
Release Date Price: $33.17 (+3.30%)
Chad Messer
Needham & Co. - Analyst

Hello, everybody, and thanks for joining us for our next presentation here at the Needham & Co. virtual healthcare conference. My name is Chad Messer; I'm one of the senior biotech analysts here at Needham. I am joined with my Needham colleague, Gil Blum, who will be helping me moderate our conversation today with management from Shattuck Labs. We have Taylor Schreiber and Andrew Neill, the CFO, joining us. Maybe we can just get right into it.

Questions & Answers

Chad Messer
Needham & Co. - Analyst

You guys have a pretty unique technology platform in your ARC, your Agonist Redirected Checkpoints. Can you just talk about that and how it's different from using small molecule or antibody -- soft of other approaches that people might use to go after similar targets?

Taylor Schreiber
Shattuck Labs, Inc. - CEO & Co-Founder

Sure we can. Thank you, Chad and Gil, for inviting us to the session. It's been a pleasure to work with you both since beginnings as a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot